Cyclodextrin controlled release of poorly water-soluble drugs from hydrogels

Drug Delivery

Volumn 15, Issue 1, 2008, Pages 69-80

  Woldum, Henriette Sie ^a   Larsen, Kim Lambertsen ^a   Madsen, Flemming ^b  

^a AALBORG UNIVERSITY   (Denmark)

^b Global R and D   (Denmark)

Author keywords

Cyclodextrins; Diffusion; Drug Release; Hydrogels

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CAVAMAX; CAVASOL; CYCLODEXTRIN; GAMMA CYCLODEXTRIN; IBUPROFEN; KETOPROFEN; PREDNISOLONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEL; MEMBRANE PERMEABILITY; PH MEASUREMENT; PRIORITY JOURNAL; STOICHIOMETRY; ULTRAVIOLET RADIATION;

ANTI-INFLAMMATORY AGENTS; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; GAMMA-CYCLODEXTRINS; HYDROGELS; HYDROGEN-ION CONCENTRATION; IBUPROFEN; KETOPROFEN; KINETICS; METHACRYLATES; MODELS, CHEMICAL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POVIDONE; PREDNISOLONE; SOLUBILITY; WATER;

EID: 38149132470     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540701829267     Document Type: Article

References (33)

1. 12 from poly(N-vinyl-2-pyrrolidone-co-acrylic acid) hydrogels. Reactive Functional Polymers 62:93-104.
2. Bibby, D. C., Davies, N. M., and Tucker, I. G. 2000. Mechanism by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharmaceut. 197:1-11.
3. Bourke, S. L., Al-Khalili, M., Briggs, T., Michniak, B. B., Kohn, J., and Poole-Warren, L. A. 2003.Aphoto-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications. AAPS PharmSci 5(4) article 33.
4. Coviello, T., Grassi, M., Palleschi, A., Bocchinfuso, G., Coluzzi, G., Banishoeib, F., and Alhaique, F. 2005 A new scleroglucan/borax hydrogel: swelling and drug release studies. Int. J. Pharmaceut. 289(1-2):97-107.
5. Davies, M.E., and Brewster, M.E. 2005. Cyclodextrin-based pharmaceutics: past present and future. Nature Rev. 3:1023-1035.
6. Díaz, D., Llanos, C. M. E., Josefa, M., Bernad, B. and Mora, J. G. 1998. Binding, molecular mechanics, and thermodynamics of cyclodextrin inclusion complexes with ketoprofen in aqueous medium. Pharmaceut. Dev. Techn. 3:307-313.
7. Filipovic-Grcic, J., Becirvic-Lacan, M., Skalko, N., and Jalsenjak, I. 1996 Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. Int. J. Pharmaceut. 135:183-190.
8. Ghorab, M. K., and Adeyeye, M. C. 2003. Enhanced bioavailability of processinduced fast-dissolving ibuprofen cogranulated with β-cyclodextrin. J. Pharmaceut. Sci. 92(8):1690-1697.
9. Higuchi, T., and Connors, K. A. 1965 Phase-solubility techniques. Adv. Anal. Chem. Instrument. 4:117-212.
10. Iervolino, M., Raghavan, S.L., and Hadgraft, J. 2000. Membrane penetration enhancement of ibuprofen using supersaturation. Int. J. Pharmaceut. 198:229-238.
11. Katime, I., Novoa, R., De Apodaca, E. D., and Rodriguez, E. 2004. Release of theophylline and aminophylline from acrylic acid/n-alkyl methacrylate hydrogels. J. Polymer Sci., Part A: Polymer Chem. 42(11):2756-2765.
12. Larsen, K.L. 2002. Large cyclodextrins. J. Inclusion Phenom. Mol. Recog. Chem. 43:1-13.
13. Larsen, K.L., Aachmann, F. L., Wimmer, R., Stella, V. J., and Madsen Kjølner, U. 2005. Phase solubility and structure of the inclusion complexes of prednisolone and 6a-methyl prednisolone with various cyclodextrins. J. Pharmaceut. Sci. 94(3):507-515.
14. Lee, W., and Lin, W. 2002. Preparation and gel properties of poly[hydroxyethylmethacrylate-co-poly(ethylene glycol) methacrylate] copolymeric hydrogels by photopolymerizaton. J. Polymer Res. 9:23-29
15. Loftsson, T., and Brewster, M. E. 1996. Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization. J. Pharmaceut. Sci. 85(10):1017-1025.
16. Loftsson, T., and Masson, M. 2001. Cyclodextrins in topical drug formulations: theory and practice. Int. J. Pharmaceut. 225:15-30.
17. Loftsson, T., and Olafsson, J. H. 1998 Cyclodextrins: new drug delivery systems in dermatology. Int. J. Dermatol. 37:241-246.
18. Mandracchia, D., Pitarresi, G., Palumbo, F. S., Carlisi, B., and Giammona, G. 2004. pH-sensitive hydrogel based on a novel photocross-linkable copolymer. Biomacromolecules 5(5):1973-1982.
19. Mogensen, B., Endo, T., Ueda, H., Zimmermann, W., and Larsen, K. L. 2000. Analysis of complex formation between large cyclodextrins and aromatic anions. Proc. 10th Int. Cyclodextrin Symp. Ann Arbor, MI, USA. May 21-24 (CD-ROM ed).
20. Montassier, P., Duchêne, Dominique, and Poelman, Marie-Christine. 1998. In vitro release study of tretinoin from tretinoin/cyclodextrin derivative complexes. J. Inclusion Phenom. Mol. Recog. Chem. 31:213-218.
21. Mura, P., Bettinetti, G. P., Manderioli, A., Faucci, M.T., Bramanti, G., and Sorrenti, M. 1998. Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state. Int. J. Pharmaceut. 166:189-203.
22. Okimoto, K., Rajewski, R.A., Uekama, K., Jana, J.A., and Stella, V.J. 1996 The interaction of charged and uncharged drugs with neutral (HB-β-CD) and anionically charged (SBE-β-CD) β-cyclodextrins. Pharmaceut. Res. 13:256-264.
23. Orienti, I., Fini, A., Bertasi, V., and Zecchi, V. 1991. Inclusion complexes between nonsteroidal anti-inflammatory drugs and β-cyclodextrins. Eur. J. Pharmaceut. Biopharmaceut. 37(2):110-112.
24. Rasmussen, M. R., Snabe, T., and Pedersen, L. H. 2003. Numerical modelling of insulin and amyloglucosidase release from swelling Ca-alginate beads. J. Controll. Rel. 91 :395-405.
25. Sridevi, S., and Diwan, P. V. R. 2002. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-β-cyclodextrin as co-enhancers. Eur. J. Pharmaceut. Biopharmaceut. 54:151-154.
26. Tomono, K., Mugishima, A., Suzuki, T., Goto, H., Ueda, H., Nagai, T., and Watanabe, J. 2002 Interaction between cycloamylose and various drugs. J. Inclusion Phenom. Macrocyclic Chem. 44:267-270.
27. Uekama, K., Fujinaga, T., Hirayama, F., Otagari, M., and Yamasaki, M. 1982. Inclusion complexations of steroid hormones with cyclodextrins in water and in solid phase. Int. J. Pharmaceut. 10:1-15.
28. Villar-López, M.E., Nieto-Reyes, L., Anguiano-Igea, S., Otero-Espinar, F. J., and Blanco-Méndez, J. 1999. Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting. Int. J. Pharmaceut. 179:229-235.
29. Wang, Z., Ikegami, K., Hirayama, F., and Uekama, K. 1993a. Release characteristics of nifedipine from 2-hydroxypropyl-b-cyclodextrin complex during storage and its modification of hybridizing polyvinylpyrrolidone K-30. Chem. Pharmaceut. Bull. 41:1822-1826.
30. Wang, Z., Hirayama, F., and Uekama, K. 1993b. Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-í-cyclodextrin and hydroxypropyl cellulose. J. Pharm. Pharmacol. 45:942-946.
31. Wang, Z., Hirayama, F., and Uekama, K. 1994. In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-β-cyclodextrin and hydroxypropyl celluloses in dogs. J. Pharm. Pharmacol. 46:505-507.
32. Wichterle, O., and Lim, D. 1960. Hydrophilic gels for biological use. Nature 185:117-118.
33. Zia, V., Rajevski, R. A., and Stella, V. J. 2001. Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-β-CD to HP-β-CD. Pharmaceut. Res. 18(5):667-673.